Cita APA (7a ed.)

Christopher J. Mowry, M., Cristina Alonso, P., Marta Iruarrizaga-Lejarreta, P., Pablo Ortiz, M., Josh Levitsky, M., & Mary Rinella, M. (2021). Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer.

Cita Chicago Style (17a ed.)

Christopher J. Mowry, MD, PhD Cristina Alonso, PhD Marta Iruarrizaga-Lejarreta, MD Pablo Ortiz, MD Josh Levitsky, y MD Mary Rinella. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.

Cita MLA (8a ed.)

Christopher J. Mowry, MD, et al. Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Wolters Kluwer, 2021.